SEC Form 4 · accession 0001013606-18-000089
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Thompson
Officer — Chief Medical Officer
Period of report
May 15, 2018
Accepted (ET)
Jun 1, 2018 · 8:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 15, 2018 | A | 31,000 | $0.00 | A | 79,411 | D | |
| Common StockF3 | May 15, 2018 | F | 10,719 | $4.87 | D | 68,692 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award was originally granted on June 15, 2015. 100% of the shares subject to this restricted stock award vested pursuant to the terms of this award.
- F2Total shares owned includes 4,488 shares purchased through the Company's Employee Stock Purchase Plan on April 30, 2018 and have not previously been disclosed due to immateriality.
- F3Shares withheld on May 15, 2018 to satisfy statutory minimum tax withholding obligations related to shares vested on May 15, 2018.